Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome
- 1 January 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 28 (1) , 1-7
- https://doi.org/10.1097/00003246-200001000-00001
Abstract
Objective: To determine whether bronchoalveolar lavage fluid (BALF) from patients either at risk for the acute respiratory distress syndrome (ARDS) or with sustained ARDS modulates neutrophil apoptosis; to measure the BALF concentrations of the apoptosis inhibitors granulocyte colony-stimulating factor (G-CSF) and granulocyte/macrophage colony-stimulating factor (GM-CSF) before and after the onset of ARDS; and to determine whether the BALF concentrations of G-CSF and/or GM-CSF are associated with clinical outcome. Design: Prospective cohort study. Setting: Tertiary university hospital. Patients: Twenty patients at risk for ARDS and 45 patients with established ARDS. Interventions: Patients at risk for ARDS underwent bronchoalveolar lavage within 24 hrs of being identified, then again 72 hrs later. Patients with ARDS underwent bronchoalveolar lavage within 24 hrs of meeting ARDS criteria, then again on days 3, 7, and 14 of the disease. Measurements and Main Results: Normal peripheral blood neutrophil were incubated overnight in BALF from normal volunteers, from patients at risk for ARDS, or from patients with ARDS. neutrophil apoptosis was determined by flow cytometric analysis of annexin V binding. G-CSF and GM-CSF were measured in BALF by immunoassays. Compared with normal BALF, BALF from patients on days 1 and 3 of ARDS inhibited neutrophil apoptosis, but BALF from patients at later stages of ARDS, or from patients at risk for ARDS, did not. The BALF concentrations of both G-CSF and GM-CSF were elevated early in ARDS and decreased toward later stages. Patients who lived had significantly higher concentrations of GM-CSF in the BALF than those who died. Conclusions: We conclude that the antiapoptotic effect of ARDS BALF on normal neutrophil is highest during early ARDS, and decreases during late ARDS. G-CSF and GM-CSF are present in BALF from patients with ARDS, and their concentrations parallel the antiapoptotic effect of ARDS BALF. These data support the concept that the life-span of neutrophil in the air spaces is modulated during acute inflammation. GM-CSF in the air spaces is associated with improved survival in patients with ARDS.Keywords
This publication has 29 references indexed in Scilit:
- Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1996
- Interleukin-6 Delays Neutrophil ApoptosisArchives of Surgery, 1996
- Clinical risks for development of the acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1995
- Granulocyte apoptosis and the control of inflammationPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1994
- Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1994
- Report of the American-European Consensus Conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordinationJournal of Critical Care, 1994
- Interleukin‐2 prevention of apoptosis in human neutrophilsEuropean Journal of Immunology, 1994
- Bronchial Epithelial Cell-derived Cytokines (G-CSF and GM-CSF Promote the Survical of Peripheral Blood Neutrophils In VitroAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- Neutrophils and Adult Respiratory Distress Syndrome: Two Interlocking Perspectives in 1991American Review of Respiratory Disease, 1991
- The biology of GM-CSF: Regulation of production and interaction with its receptorThe International Journal of Cell Cloning, 1990